Phreesia Business Summary

Phreesia, Inc. (PHR) operates a high-growth SaaS platform designed to automate patient intake and optimize the financial and clinical performance of healthcare organizations. The company generates revenue through three primary streams: subscription fees for its core software, transaction fees from its integrated payment processing solutions, and network solutions fees paid by life sciences companies and health plans for direct patient communication and data-driven engagement. Following its November 2025 acquisition of AccessOne, Phreesia has significantly expanded its footprint into healthcare receivables financing, integrating scalable patient payment plans into its ecosystem. The company competes directly with patient engagement and revenue cycle management providers such as Luma Health, Waystar, Doximity, and Solutionreach, maintaining a dominant market position as the leading end-to-end patient activation platform with a presence in approximately one in seven U.S. patient visits. Phreesia was co-founded in 2005 by CEO Chaim Indig and Evan Roberts, currently President of Provider Solutions, both of whom previously held leadership roles at the analytics firm Spotfire (acquired by TIBCO). The executive team is further anchored by CFO Balaji Gandhi, a veteran of Fresenius Medical Care and Press Ganey, and CTO Jack Callahan, who also brings deep technical pedigree from Spotfire. The company’s governance is currently undergoing a strategic refresh; as of February 2026, long-time directors Edward L. Cahill and Board Chair Michael Weintraub have announced their upcoming retirement, with industry veteran Jon Kessler (former CEO of HealthEquity) appointed to the board effective April 2026. Phreesia maintains a robust institutional investor base, with significant historical backing from firms like Polaris Partners and high current ownership by major asset managers, reflecting its status as a mature, publicly traded leader in the digital health space.